<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0127">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Guo</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dong</surname>
    <given-names>X</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group> (
  <year>2018</year>). 
  <article-title>In vivo evaluation of reduction-responsive alendronate-hyaluronan-curcumin polymer-drug conjugates for targeted therapy of bone metastatic breast cancer</article-title>. 
  <source>Mol Pharm</source>
  <volume>15</volume>:
  <fpage>2764</fpage>–
  <lpage>69</lpage>.
  <pub-id pub-id-type="pmid">29792799</pub-id>
 </mixed-citation>
</ref>
